Ulla‐Maija Haltia

FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype

Ulla‐Maija Haltia, Ralf Bützow, Arto Leminen et al. · Journal of Gynecologic Oncology · 2014 · 48 citations · Full text

Optimized detection of homologous recombination deficiency improves the prediction of clinical outcomes in cancer

Fernando Pérez‐Villatoro, Jaana Oikkonen, Julia Casado et al. · npj Precision Oncology · 2022 · 44 citations · Full text

Homologous Recombination Deficiency, Breast Oncology, Machine Learning +17

Real‐life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (<scp>RESPONSE</scp> trial)

Christian Marth, Miguel Henriques Abreu, Klaus Kaae Andersen et al. · Cancer · 2022 · 41 citations · Full text

Systematic drug sensitivity testing reveals synergistic growth inhibition by dasatinib or mTOR inhibitors with paclitaxel in ovarian granulosa cell tumor cells

Ulla‐Maija Haltia, Noora Andersson, Bhagwan Yadav et al. · Gynecologic Oncology · 2017 · 34 citations · Full text

Mtor Inhibitors, Medicine, Pharmacology +7

Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Müllerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors

Ulla‐Maija Haltia, Marianne Hallamaa, Johanna Tapper et al. · Gynecologic Oncology · 2016 · 26 citations · Full text

Autoimmune Disease, Anti-müllerian Hormone, Immunology +10